OPTINOSE, INC. SECOND AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENTShareholders Agreement • September 18th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 18th, 2017 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENT (the “Agreement”), dated as of March 24, 2017, by and among the following parties (each, a “Party” and collectively, the “Parties”):
OPTINOSE, INC. SECOND AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENTShareholders Agreement • June 26th, 2017 • OptiNose, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 26th, 2017 Company Industry JurisdictionTHIS SECOND AMENDED AND RESTATED SHAREHOLDERS’ AGREEMENT (the “Agreement”), dated as of March 24, 2017, by and among the following parties (each, a “Party” and collectively, the “Parties”):